Literature DB >> 12390309

The transmembrane form of TNF-alpha drives autoantibody production in the absence of CD154: studies using MRL/Mp-Fas(lpr) mice.

T Fujii1, M Okada, T Mimori, J Craft.   

Abstract

It is generally accepted that the interaction between CD40 and its ligand (CD154) plays a decisive role in contact-dependent help for T and B cells. In CD154-deficient MRL/Mp-Fas(lpr) (MRL/lpr) mice, however, high titres of IgG2a-type autoantibodies against small nuclear ribonucleoproteins (snRNPs) are observed. We successfully isolated two CD154-deficient MRL/lpr Th1 lines, which could provide B cell help for anti-snRNP antibody production. The proliferative responses of the Th1 cell lines were MHC class II (I-Ek)-restricted. Although syngeneic B cell proliferation was induced by Th1 lines in both a contact-dependent and -independent manner, the soluble form of TNF-alpha (sTNF-alpha) was not involved in contact-independent B cell proliferation. On the other hand, both anti-TNF-alpha and TNF-receptor 2 (TNF-R2, p75) monoclonal antibody (MoAb) blocked contact-dependent B cell proliferation, suggesting that the transmembrane form of TNF-alpha (mTNF-alpha)-TNF-R2 co-stimulation participates in B cell activation. Similarly, anti-TNF-alpha and TNF-R2 MoAb inhibited anti-snRNP antibody production in vitro, but anti-CD154 or TNF-R1 MoAb did not. These results indicate that the interaction of mTNF-alpha on activated Th1 cells with TNF-R2 on B cells may be involved in the autoimmunity seen in MRL mice, and that the blockade of CD40-CD154 co-stimulation may not always be able to suppress some Th1-related manifestations of lupus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390309      PMCID: PMC1906522          DOI: 10.1046/j.1365-2249.2002.01982.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  48 in total

1.  CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses.

Authors:  S Morimoto; Y Kanno; Y Tanaka; Y Tokano; H Hashimoto; S Jacquot; C Morimoto; S F Schlossman; H Yagita; K Okumura; T Kobata
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

2.  Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.

Authors:  M Koshy; D Berger; M K Crow
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  alpha beta T cell regulation and CD40 ligand dependence in murine systemic autoimmunity.

Authors:  S L Peng; J M McNiff; M P Madaio; J Ma; M J Owen; R A Flavell; A C Hayday; J Craft
Journal:  J Immunol       Date:  1997-03-01       Impact factor: 5.422

4.  Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha.

Authors:  M L Moss; S L Jin; M E Milla; D M Bickett; W Burkhart; H L Carter; W J Chen; W C Clay; J R Didsbury; D Hassler; C R Hoffman; T A Kost; M H Lambert; M A Leesnitzer; P McCauley; G McGeehan; J Mitchell; M Moyer; G Pahel; W Rocque; L K Overton; F Schoenen; T Seaton; J L Su; J D Becherer
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

5.  A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells.

Authors:  R A Black; C T Rauch; C J Kozlosky; J J Peschon; J L Slack; M F Wolfson; B J Castner; K L Stocking; P Reddy; S Srinivasan; N Nelson; N Boiani; K A Schooley; M Gerhart; R Davis; J N Fitzner; R S Johnson; R J Paxton; C J March; D P Cerretti
Journal:  Nature       Date:  1997-02-20       Impact factor: 49.962

6.  Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice.

Authors:  K Akassoglou; L Probert; G Kontogeorgos; G Kollias
Journal:  J Immunol       Date:  1997-01-01       Impact factor: 5.422

7.  CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice: phenotype and possible role in autoreactivity.

Authors:  H Lettesjö; G P Burd; R A Mageed
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

8.  Induction of nonpathologic, humoral autoimmunity in lupus-prone mice by a class II-restricted, transgenic alpha beta T cell. Separation of autoantigen-specific and -nonspecific help.

Authors:  S L Peng; S Fatenejad; J Craft
Journal:  J Immunol       Date:  1996-12-15       Impact factor: 5.422

9.  Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.

Authors:  G S Early; W Zhao; C M Burns
Journal:  J Immunol       Date:  1996-10-01       Impact factor: 5.422

10.  CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L.

Authors:  S Shinde; Y Wu; Y Guo; Q Niu; J Xu; I S Grewal; R Flavell; Y Liu
Journal:  J Immunol       Date:  1996-10-01       Impact factor: 5.422

View more
  3 in total

1.  Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.

Authors:  Yoshimasa Fujita; Takao Fujii; Tsuneyo Mimori; Tomomi Sato; Takuji Nakamura; Haruka Iwao; Akio Nakajima; Miyuki Miki; Tomoyuki Sakai; Takafumi Kawanami; Masao Tanaka; Yasufumi Masaki; Toshihiro Fukushima; Toshiro Okazaki; Hisanori Umehara
Journal:  J Immunol       Date:  2014-01-03       Impact factor: 5.422

2.  SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus.

Authors:  Martin Aringer; Josef S Smolen
Journal:  Arthritis Res Ther       Date:  2003-05-14       Impact factor: 5.156

3.  Context-dependent induction of autoimmunity by TNF signaling deficiency.

Authors:  Tam D Quach; Weiqing Huang; Ranjit Sahu; Catherine Mm Diadhiou; Chirag Raparia; Roshawn Johnson; Tung Ming Leung; Susan Malkiel; Peta Gay Ricketts; Stefania Gallucci; Çagla Tükel; Chaim O Jacob; Martin L Lesser; Yong-Rui Zou; Anne Davidson
Journal:  JCI Insight       Date:  2022-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.